Joerg Hipp, PhD

Dr. Joerg Hipp is a biomarker and experimental medicine leader at F. Hoffmann-La Roche. He has a background in Physics and Neuroscience. Before joining Roche, his main research focus was to understand the role of neuronal oscillations in normal and pathological brain function using different techniques including EEG, MEG and MRI. At Roche, he is responsible for the biomarker strategy and implementation in several drug development programs with a focus on neurodevelopmental disorders (including Angelman syndrome, Dup15q syndrome) and he heads the group Electrophysiology & Analytics that supports across the neuroscience portfolio (Publications: